Publications

In this report, a multi-disciplinary attempt to synthesize available data and analyses on drugs and drug addiction has been made, in order to avoid the usual over-segmented approaches taken in this field. 

The fourth edition of this report provides a clearer picture of the extent and complexity of the drug problem, how it has evolved over the past few years, and the measures implemented. The aim of this document is to put all the available knowledge into perspective.

This manual presents the main results of a European project whose purpose is to develop a common model of an Early Information Function for Emerging Drug Phenomena. This function should allow to identify and understand early changes in drug uses or new drugs more quickly than by using standard monitoring systems.

This report tries to bring about some facts to answer three basic questions: how many people use drugs in France, as regards a single experience or a more regular one? Which users are in trouble? Which sanitary, social and legal damages are caused by these uses?

The aim of this document is to illustrate the different aspects of the situation of cannabis in France (consumption, market, risks and consequences, public policy, etc.).

These guidelines are the result of the work carried out within the framework of the Addictions Committee set up by the Ministry of Health in November 2006. 

This 30-page document gives an estimate, between 210 000 and 250 000 problem drug users, based on data from 2006 and different methods.

Until now, most of our available knowledge on the NPS (new/novel psychoactive substance) phenomenon originated from traditional information systems on drugs and drug addiction (data on seizures and treatment demands, monitoring in a recreational setting, etc.). 

Within the vast category of new psychoactive substances, 25x-NBOMe or NBOMe represents a group of compounds in the phenethylamine family, which mainly has a hallucinogenic and psychedelic effect in particular.

This summary covers the main contributions from a collective OFDT publication entitled "Drogues et addictions, données essentielles" issued in April 2019.

This Théma report is devoted to the changes in the cannabis market in France, particularly in relation to the increase in the use of herbal cannabis.

What is the extent and nature of illicit drug use in prisons in France? What are the consequences and what responses are being provided?

On the 20th anniversary of the Emerging Trends and New Drugs (TREND) scheme and the National Detection System of Drugs and Toxic Substances (SINTES), the French Monitoring Centre for Drugs and Drug Addiction (OFDT) looks back on two decades of drug monitoring. 

This report analyzes the regulation of cannabis in Canada, as well as the political, economic and social impact of the policies adopted.

This is a review and synthesis of the scientific literature on public health effects of liberalization of marijuana prohibition in the United States. 

This report summarizes eight years of policy and public health knowledge since Colorado and Washington became the first states in the U.S. – and the first jurisdictions in the world – to begin to develop and implement policies around a commercial marketplace for marijuana.

The aim of this Théma is to provide an overview of the situations and problems currently observed in the French overseas territories with regard to drugs and addictions, based on the most recent statistical data and the main studies carried out in these territories.

A review of the international literature on online sports betting demonstrates that current knowledge about so-called “problem” sports betting remains largely unknown. Although the data is incomplete among the general population, “excessive” practices have nevertheless been noted, in particular through surveys of Internet users.

In the general context of a background of booming global cocaine production, this Théma report provides an assessment of the situation in France.